Alternatively spliced tissue factor promotes breast cancer growth in a β1 integrin-dependent manner.
about
Tissue Factor-Factor VII Complex As a Key Regulator of Ovarian Cancer Phenotypes"Soluble Tissue Factor" in the 21st Century: Definitions, Biochemistry, and Pathophysiological Role in Thrombus FormationTissue factor associates with survival and regulates tumour progression in osteosarcoma.Tissue Factor promotes breast cancer stem cell activity in vitro.Tissue factor in tumor microenvironment: a systematic reviewBreast cancer phenotypes regulated by tissue factor-factor VII pathway: Possible therapeutic targets.Role of the protein C receptor in cancer progression.Orthotopic injection of breast cancer cells into the mammary fat pad of mice to study tumor growth.Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF.Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin aAlternatively spliced tissue factor synergizes with the estrogen receptor pathway in promoting breast cancer progression.Methylation associated genes contribute to the favorable prognosis of gliomas with isocitrate dehydrogenase 1 mutation.Colon Cancer Growth and Dissemination Relies upon Thrombin, Stromal PAR-1, and Fibrinogen.Antibody-based targeting of alternatively spliced tissue factor: a new approach to impede the primary growth and spread of pancreatic ductal adenocarcinoma.Predicting cancer-relevant proteins using an improved molecular similarity ensemble approach.Competing endogenous RNA network analysis identifies critical genes among the different breast cancer subtypes.Extracellular vesicles, tissue factor, cancer and thrombosis - discussion themes of the ISEV 2014 Educational DayActivation of carbonic anhydrase IX by alternatively spliced tissue factor under late-stage tumor conditionsInterplay between alternatively spliced Tissue Factor and full length Tissue Factor in modulating coagulant activity of endothelial cells.Targeting clotting proteins in cancer therapy - progress and challenges.Microparticle association and heterogeneity of tumor-derived tissue factor in plasma: is it important for coagulation activation?Contributions of thrombin targets to tissue factor-dependent metastasis in hyperthrombotic mice.Pathological expression of tissue factor confers promising antitumor response to a novel therapeutic antibody SC1 in triple negative breast cancer and pancreatic adenocarcinoma.Identification of the coagulation factor VIIa integrin binding site required for pro-angiogenic PAR2 signaling.Levels of Alternatively Spliced Tissue Factor in the Plasma of Patients with Pancreatic Cancer May Help Predict Aggressive Tumor Phenotype.Comprehensive analysis of haemostatic profile depending on clinicopathological determinants in breast cancer patients.
P2860
Q26781924-367F70A0-4671-4086-8B11-D91EED22DA1CQ26786677-145398FE-EFFA-40A6-8F4A-4E497DB31C1AQ33672303-EE6D6D0F-6625-443C-A225-72C13F3BE745Q33688466-5B6BAB77-21B2-4D2B-B91D-CFF7AF0EF7D5Q34544801-E0CB3112-C2F3-4AFE-94FD-7D9CE90E86FCQ34657739-6013AE53-FE0A-4E7E-AE06-2CEA1EF8C43EQ34731385-FCA1396F-6973-4CDD-A920-C4F9126E07CDQ35162196-DC14F17B-6B09-4B85-8772-D9AAF6725128Q35579053-5DADF64C-ED8D-442F-AF66-7B2738CE1F84Q35676447-1208782C-968E-4610-B6D1-BDE87351B5D3Q36030868-711BB5DF-A712-4B75-9DCC-F038C46129B5Q36249145-9282A2C4-98FE-4531-998F-E892385A70B6Q36732743-5230EA70-FAD1-4AC2-9EFA-3BADC1CCB82FQ37295308-66ADF4B1-FC04-45FE-BFA6-54B9932D8419Q37362677-1C442173-C27D-48A4-82F1-3787A0CDDCDEQ37705802-A3264AFA-26C4-4AF8-8BAA-17383D734C17Q38379177-3B200493-6357-443F-BB5A-85FC06A49748Q38741821-537B2E97-A3B9-481D-9AF6-3FE1540DB666Q38750674-19EDD47A-5140-4779-ABC3-FD93C4A9AAA6Q38805371-E21D2435-2CD8-4A55-8443-F0F87D860EA9Q39050585-4D03F98A-FA4C-4CD4-A75E-DB539E650950Q39068369-8CFD7CCD-6A2E-4A03-8B4D-E8044EA6430FQ41709078-3D8DEFF7-FDE7-441A-9BF8-2D9F6D8E0469Q47287709-CC2774A6-7774-4C3C-ABC3-CCC1A3E92258Q53511211-21430F84-5C06-43D2-A767-50D46798D724Q54939232-643CF52F-AC77-4A0A-A68D-E18E01402D62
P2860
Alternatively spliced tissue factor promotes breast cancer growth in a β1 integrin-dependent manner.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Alternatively spliced tissue f ...... β1 integrin-dependent manner.
@en
Alternatively spliced tissue f ...... β1 integrin-dependent manner.
@nl
type
label
Alternatively spliced tissue f ...... β1 integrin-dependent manner.
@en
Alternatively spliced tissue f ...... β1 integrin-dependent manner.
@nl
prefLabel
Alternatively spliced tissue f ...... β1 integrin-dependent manner.
@en
Alternatively spliced tissue f ...... β1 integrin-dependent manner.
@nl
P2093
P2860
P50
P356
P1476
Alternatively spliced tissue f ...... a β1 integrin-dependent manner
@en
P2093
Charla C Engels
Cornelis J Van de Velde
Esther M de Kruijf
Gerrit-Jan Liefers
J Sven D Mieog
Martijn A van der Ent
Pieter H Reitsma
Susanne Osanto
Vladimir Y Bogdanov
Wolfram Ruf
P2860
P304
11517-11522
P356
10.1073/PNAS.1307100110
P407
P577
2013-06-25T00:00:00Z